Cite
Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma
MLA
Attolico, Immacolata, et al. “Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma.” Biology of Blood & Marrow Transplantation, vol. 18, no. 2, Feb. 2012, pp. 241–49. EBSCOhost, https://doi.org/10.1016/j.bbmt.2011.07.014.
APA
Attolico, I., Pavone, V., Ostuni, A., Rossini, B., Musso, M., Crescimanno, A., Martino, M., Iacopino, P., Milone, G., Tedeschi, P., Coluzzi, S., Nuccorini, R., Pascale, S., Di Nardo, E., & Olivieri, A. (2012). Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma. Biology of Blood & Marrow Transplantation, 18(2), 241–249. https://doi.org/10.1016/j.bbmt.2011.07.014
Chicago
Attolico, Immacolata, Vincenzo Pavone, Angelo Ostuni, Bernardo Rossini, Maurizio Musso, Alessandra Crescimanno, Massimo Martino, et al. 2012. “Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma.” Biology of Blood & Marrow Transplantation 18 (2): 241–49. doi:10.1016/j.bbmt.2011.07.014.